Integration of genetic, proteomic, and transcriptomic data identifies therapeutic targets and prognostic biomarkers in bladder cancer. Han K, Wei C, Li Y, Luo Y, et al. Transl Androl Urol 2025;14:3472-3492.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han K, Wei C, Li Y, Luo Y, et al. Integration of genetic, proteomic, and transcriptomic data identifies therapeutic targets and prognostic biomarkers in bladder cancer. Transl Androl Urol 2025;14:3472-3492.
PMID: 41368242